NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 38 filers reported holding NRX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,320 | -4.2% | 31,999 | +76.8% | 0.00% | – |
| Q2 2023 | $8,688 | -86.7% | 18,100 | -81.7% | 0.00% | – |
| Q1 2023 | $65,151 | -32.3% | 98,823 | +13.9% | 0.00% | – |
| Q4 2022 | $96,268 | -12.5% | 86,728 | -41.4% | 0.00% | – |
| Q3 2022 | $110,000 | -11.3% | 147,885 | -28.0% | 0.00% | – |
| Q2 2022 | $124,000 | -80.0% | 205,374 | -18.8% | 0.00% | – |
| Q1 2022 | $620,000 | -81.0% | 253,009 | -62.9% | 0.00% | – |
| Q4 2021 | $3,256,000 | +6.1% | 681,712 | +106.0% | 0.00% | – |
| Q3 2021 | $3,068,000 | – | 330,928 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 699,731 | $338,320 | 0.28% |
| CVI Holdings, LLC | 483,569 | $233,806 | 0.25% |
| ARMISTICE CAPITAL, LLC | 5,636,000 | $2,725,006 | 0.04% |
| Texas Capital Bank Wealth Management Services Inc | 63,290 | $30,601 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 160,700 | $77,698 | 0.00% |
| HBK Sorce Advisory LLC | 29,230 | $14,133 | 0.00% |
| United Asset Strategies, Inc. | 18,300 | $8,848 | 0.00% |
| JANE STREET GROUP, LLC | 15,052 | $7,278 | 0.00% |
| UBS Group AG | 2,758 | $1,332 | 0.00% |
| NewEdge Advisors, LLC | 2,125 | $1,028 | 0.00% |